>
Pharmacology
NF-
B Needs PPAR
Nancy R. Gough
Science Signaling, AAAS, Washington, DC 20005, USA
Peroxisome proliferator–activated receptor-
(PPAR
) is a ligand-dependent transcription factor, and agonists of this receptor have been used to treat type 2 diabetes and kidney diseases associated with inflammation. PPAR
agonists reduced the production of inflammatory mediators in response to proinflammatory signals such as those mediated by tumor necrosis factor–
(TNF-
), which activates the transcription factor nuclear factor
B (NF-
B). Wen et al. report opposite ligand-independent and ligand-dependent functions for PPAR
in regulating the expression of NF-
B target genes. Incubation of rat glomerular mesangial cells with natural or synthetic PPAR
agonists reduced TNF-
–stimulated production of the proinflammatory mediators RANTES and MCP-1. A cell-permeable inhibitor of NF-
B also blocked RANTES production in response to TNF-
; however, the PPAR
agonists failed to reduce early events in NF-
B activation and did not prevent nuclear translocation of NF-
B subunits. Instead, PPAR
agonists blocked the association of PPAR
with the NF-
B subunit p65, which was detected by coimmunoprecipitation, following TNF-
stimulation. Chromatin immunoprecipitation experiments with a portion of the RANTES promoter revealed that p65 from TNF-
–stimulated cells bound to the promoter and that this interaction was reduced if the cells were also exposed to PPAR
agonists. Consistent with this model that unliganded PPAR
promotes NF-
B binding to this promoter, knockdown of PPAR
blocked the induction of RANTES and association of p65 at the RANTES promoter by TNF-
in the mesangial cells. Thus, PPAR
appears to have a dual function in inflammatory signaling: Unliganded PPAR
promotes NF-
B binding to target gene promoters (proinflammatory), and agonist-bound PPAR
inhibits this NF-
B binding (anti-inflammatory).
X. Wen, Y. Li, Y. Liu, Opposite action of peroxisome proliferator-activated receptor-
in regulating renal inflammation: Functional switch by its ligand. J. Biol. Chem. 285, 29981–29988 (2010). [Abstract] [Full Text]